Table 2.
Prescription and use of pharmacological therapy after Hospital Discharge in patients with ACS, Aracaju, Sergipe, Brazil.
| Pharmacological Therapy | Patients Indicated to use medication at HD | PI at 30 days post-ACS |
Patients Interviewed at 30 days post-ACS |
PI at 180 days post-ACS |
Patients Interviewed at 180 days post-ACS |
||
|---|---|---|---|---|---|---|---|
| WM (%) | NM (%) | WM (%) | NM (%) | ||||
| ASA | 532 (95.8) | 498 | 478 (96.0) | 20 (4.0) | 469 | 434 (92.5) | 35 (7.5) |
| Other Antiplatelets | 544 (98.0) | 512 | 481 (93.9) | 31 (6.1) | 483 | 428 (88.6) | 55 (11.4) |
| Statins | 521 (93.9) | 489 | 437 (89.4) | 52 (10.6) | 466 | 388 (83.3) | 78 (16.7) |
| β-Blockers | 493 (88.8) | 466 | 432 (92.7) | 34 (7.3) | 441 | 392 (88.9) | 49 (11.1) |
| ACEI/ARB | 473 (85.2) | 450 | 409 (90,9) | 41 (9.1) | 422 | 357 (84.6) | 65 (15.4) |
Patients who were discharged = 555; HD = Hospital discharge; ACS = Acute Coronary Syndrome; PI = Patients Interviewed; WM = With Medication; NM = No medication; ASA = Acetylsalicylic Acid; ACEI = Angiotensin Converting Enzyme Inhibitors; ARB = Angiotensin II Receptor Blockers.